Belgian Securities Regulator Asks for Take-over Bid but Suspends Action
ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Legal Matter
Release of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
Berlin, 28. April 2009 - The Belgian Securities Regulator CBFA today has required Eckert & Ziegler (ISIN DE0005659700) to launch a mandatory public take-over bid for International Brachytherapy at 3.47 EUR per share. An appeal at the Court of Appeal in Brussels is allowed and the CBFA accepted to suspend any action until a preliminary decision is taken there. Furthermore, the CBFA acknowledged that in a takeover bid, in the event that it would take place, a cash offer would not be necessary.
Information and Explaination of the Issuer to this News:
Eckert & Ziegler maintains that it has not violated any rules and that it is determined to vigorously defend the position that no public take-over bid is required. It will appeal against the CBFA decision. It is pleased that a cash offer would not be necessary in any case, and that the CBFA has abstained from immediate actions that it otherwise could have taken. The above also confirms that the case is far from clear-cut. Eckert & Ziegler hence remains optimistic that the court will decide in its favour.
For more details on the case and the law suit please see also our press releases of 16 February and 18 March 2009.
Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.de
28.04.2009 Financial News transmitted by DGAP
Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG Robert-Rössle-Str. 10
13125 Berlin
Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, München, Hamburg, Düsseldorf
End of News DGAP News-Service